NM_000492.4(CFTR):c.1647T>G (p.Ser549Arg) AND ivacaftor response - Efficacy
- Germline classification:
- drug response (1 submission)
- Last evaluated:
- Mar 24, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000211129.5
Allele description [Variation Report for NM_000492.4(CFTR):c.1647T>G (p.Ser549Arg)]
NM_000492.4(CFTR):c.1647T>G (p.Ser549Arg)
Condition(s)
- Name:
- ivacaftor response - Efficacy
- Identifiers:
- MedGen: CN322735
-
pollen allergen Sec c 4, partial [Secale cereale]
pollen allergen Sec c 4, partial [Secale cereale]gi|55859454|emb|CAH92627.1|Protein
-
pH sensitive maxi K+ channel [Mus musculus]
pH sensitive maxi K+ channel [Mus musculus]gi|86646082|gb|AAB99742.2|Protein
-
UI-R-BJ1-aue-e-05-0-UI.s10 UI-R-BJ1 Rattus norvegicus cDNA clone UI-R-BJ1-aue-e-...
UI-R-BJ1-aue-e-05-0-UI.s10 UI-R-BJ1 Rattus norvegicus cDNA clone UI-R-BJ1-aue-e-05-0-UI 3', mRNA sequencegi|45191377|gnl|dbEST|21780377|gb|C 98.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 16, 2024